Dead bacteria keep stitching DNA, opening path to engineered biomaterials

Researchers at Aarhus University have shown that bacterial cells can continue to synthesize DNA even after they have lost the ability to divide, a phenomenon the team has dubbed “zombie bacteria.” The finding overturns the long‑standing view that DNA replication halts the moment a cell dies.

In laboratory experiments the scientists treated common bacterial strains with lethal agents and then monitored the intracellular processes that followed. Using fluorescent markers that bind to newly formed nucleic acids, they observed a burst of DNA synthesis persisting for several hours after the cells were confirmed dead by standard viability assays. The work demonstrates that the enzymatic machinery required for polymerising nucleotides can remain active independent of the cell’s overall metabolic state.

Crucially, the team also discovered a method to steer which genetic sequences are produced in these post‑mortem cells. By supplying synthetic DNA templates alongside the bacterial cultures, they were able to direct the zombie bacteria to assemble predefined strands of genetic material. This level of control suggests that dead microbes could be repurposed as tiny, self‑contained factories for producing custom nucleic‑acid products without the risk of uncontrolled growth.

The implications extend beyond basic microbiology. If the approach can be scaled, it may enable the creation of novel biological materials, such as programmable hydrogels or biodegradable scaffolds, that are assembled from the inside out by these inert yet chemically active cells. Because the process does not rely on living organisms, it could sidestep many regulatory and safety hurdles associated with genetically modified microbes.

While the research is still in its early stages, the authors caution that further work is needed to understand the limits of DNA synthesis after death and to prevent unintended environmental release. Future studies will likely explore a broader range of bacterial species, assess the stability of the produced DNA, and investigate how the technique can be integrated with existing synthetic‑biology pipelines. If successful, the “zombie bacteria” platform could add a new tool to the growing toolbox of bio‑fabrication technologies.